Birchview Capital Lp

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Biodesix, Inc.
BDSX
$7.42M4.535.19M0%+$00.41
Accelerate Diagnostics, Inc.
AXDX
$321,986.001.48325,239+44.4%+$98,999.810.02
Foghorn Therapeutics Inc.
FHTX
$2.15M0.58320,9300%+$00.12
DocGo Inc.
DCGO
$1.86M0.45460,000+206.67%+$1.25M0.1
Harrow Health, Inc.
HROW
$1.98M0.42150,0000%+$00.11
Stoke Therapeutics, Inc.
STOK
$2.83M0.4210,0000%+$00.16
Silk Road Medical, Inc
SILK
$2.9M0.4158,0940%+$00.16
Karyopharm Therapeutics Inc.
KPTI
$709,446.000.4469,8320%+$00.04
AxoGen, Inc.
AXGN
$1.4M0.4173,0000%+$00.08
Prothena Corporation plc
PRTA
$4.2M0.32169,5740%+$00.23
Coherus BioSciences, Inc.
CHRS
$645,300.000.24270,000+145.46%+$382,400.000.04
Phreesia, Inc.
PHR
$2.74M0.2114,7000%+$00.15
bluebird bio, Inc.
BLUE
$411,136.000.17321,2000%+$00.02
Travere Therapeutics, Inc.
TVTX
$940,620.000.16122,0000%+$00.05
G1 Therapeutics, Inc.
GTHX
$345,600.000.1580,0000%+$00.02
ACADIA Pharmaceuticals Inc.
ACAD
$4.63M0.15250,400+4.16%+$184,900.000.26
KalVista Pharmaceuticals, Inc.
KALV
$545,560.000.1146,000+15%+$71,160.000.03
QuidelOrtho Corporation
QDEL
$3.13M0.165,2030%+$00.17
Protagonist Therapeutics, Inc.
PTGX
$1.39M0.0848,0000%+$00.08
Neurocrine Biosciences, Inc.
NBIX
$10.65M0.0877,2400%+$00.59
Alphatec Holdings, Inc.
ATEC
$1.21M0.0688,0000%+$00.07
Gossamer Bio, Inc.
GOSS
$163,048.000.06138,1760%+$00.01
Castle Biosciences, Inc.
CSTL
$310,100.000.0514,000+40%+$88,600.000.02
Corcept Therapeutics Incorporated
CORT
$1.26M0.0550,0000%+$00.07
Cullinan Oncology, Inc.
CGEM
$427,943.000.0425,1140%+$00.02
Kiniksa Pharmaceuticals, Ltd.
KNSA
$591,900.000.0430,0000%+$00.03
Bristol-Myers Squibb Company
BMY
$38.16M0.04703,606+0.19%+$70,932.792.11
Wave Life Sciences Ltd.
WVE
$246,800.000.0340,0000%+$00.01
Ovintiv Inc.
OVV
$4.37M0.0384,2000%+$00.24
Equitrans Midstream Corporation
ETRN
$1.66M0.03133,0500%+$00.09
Alkermes plc
ALKS
$1.35M0.0350,0000%+$00.08
Masimo Corporation
MASI
$2.24M0.0315,2800%+$00.12
10x Genomics, Inc.
TXG
$1.13M0.0330,0000%+$00.06
United Therapeutics Corporation
UTHR
$2.53M0.0311,0000%+$00.14
Zentalis Pharmaceuticals, Inc.
ZNTL
$252,160.000.0216,0000%+$00.01
Progyny, Inc.
PGNY
$839,300.000.0222,0000%+$00.05
Arvinas, Inc.
ARVN
$619,200.000.0215,0000%+$00.03
Cabaletta Bio, Inc.
CABA
$170,600.000.0210,0000%+$00.01
Xencor, Inc.
XNCR
$272,199.000.0212,3000%+$00.02
Keros Therapeutics, Inc.
KROS
$463,400.000.027,0000%+$00.03
Apellis Pharmaceuticals, Inc.
APLS
$1.06M0.0218,0000%+$00.06
SpringWorks Therapeutics, Inc.
SWTX
$492,200.000.0110,0000%+$00.03
Xenon Pharmaceuticals Inc.
XENE
$430,500.000.0110,0000%+$00.02
Amicus Therapeutics, Inc.
FOLD
$329,840.000.0128,0000%+$00.02
Cytokinetics, Incorporated
CYTK
$701,100.000.0110,000-60%-$1.05M0.04
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$402,792.000.017,3650%+$00.02
Axsome Therapeutics, Inc.
AXSM
$319,200.000.014,000New+$319,200.000.02
Halozyme Therapeutics, Inc.
HALO
$406,800.000.0110,0000%+$00.02
Sarepta Therapeutics, Inc.
SRPT
$323,650.00<0.012,5000%+$00.02
Inhibrx, Inc.
INBX
$1.69B<0.0148,4480%+$093.67